Advanced search
Publication Cover
International Journal of Hyperthermia Volume 36, 2019 - Issue 1
Submit an article Journal homepage
3,254
Views
25
CrossRef citations to date
0
Altmetric
Original Articles

Combined therapeutic effects of HIFU, GnRH-a and LNG-IUS for the treatment of severe adenomyosis

Xinhua YangDepartment of Gynecology, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, PR ChinaView further author information
,
Xiaofei ZhangDepartment of Gynecology, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, PR ChinaCorrespondence[email protected]
View further author information
,
Bin LinDepartment of Gynecology, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, PR ChinaView further author information
,
Xiao FengDepartment of Gynecology, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, PR ChinaView further author information
&
Aixingzi AiliDepartment of Gynecology, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, PR ChinaView further author information
Pages 485-491 | Received 11 Dec 2018, Accepted 10 Mar 2019, Published online: 17 Apr 2019

References

  • Taneichi A, Fujiwara H, Takahashi Y, et al. Influences of uterine adenomyosis on muscle invasion and prognosis of endometrioid adenocarcinoma. Int J Gynecol Cancer. 2014;24:1429–1433.
  • Gordts S, Grimbizis G, Campo R. Symptoms and classification of uterine adenomyosis, including the place of hysteroscopy in diagnosis. Fertil Steril. 2018;109:380–388.e1.
  • Grimbizis GF, Mikos T, Tarlatzis B. Uterus-sparing operative treatment for adenomyosis. Fertil Steril. 2014;101:472–487.
  • Sheth SS, Ray SS. Severe adenomyosis and CA125. J Obstet Gynaecol. 2014;34:79–81.
  • Abbott JA. Adenomyosis and Abnormal Uterine Bleeding (AUB-A)-pathogenesis, diagnosis, and management. Best Prac Res Clin Obstet Gynaecol. 2017;40:68–81.
  • Hulka CA, Hall DA, McCarthy K, et al. Sonographic findings in patients with adenomyosis: can sonography assist in predicting extent of disease? Am J Roentgenol. 2002;179:379–383.
  • Tsui KH, Lee WL, Chen CY, et al. Medical treatment for adenomyosis and/or adenomyoma. Taiwan J Obstet Gynecol. 2014;53:459–465.
  • Dueholm M. Minimally invasive treatment of adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2018;51:119–137.
  • Zhang L, Rao F, Setzen R. High intensity focused ultrasound for the treatment of adenomyosis: selection criteria, efficacy, safety and fertility. Acta Obstet Gynecol Scand. 2017;96:707–714.
  • Elhelf IAS, Albahar H, Shah U, et al. High intensity focused ultrasound: the fundamentals, clinical applications and research trends. Diagn Interv Imaging. 2018;99:349–359.
  • Liu X, Wang W, Wang Y, et al. Clinical predictors of long-term success in ultrasound-guided high-intensity focused ultrasound ablation treatment for adenomyosis: a retrospective study. Medicine. 2016;95:e2443.
  • Shui L, Mao S, Wu Q, et al. High-intensity focused ultrasound (HIFU) for adenomyosis: two-year follow-up results. Ultrason Sonochem. 2015;27:677–681.
  • Rickes D, Nickel I, Kropf S, et al. Increased pregnancy rates after ultralong postoperative therapy with gonadotropin-releasing hormone analogs in patients with endometriosis. Fertil Steril. 2002;78:757–762.
  • Grandi G, Farulla A, Sileo FG, et al. Levonorgestrel-releasing intra-uterine systems as female contraceptives. Exp Opin Pharmacother. 2018;19:677–686.
  • Zhang P, Song K, Li L, et al. Efficacy of combined levonorgestrel-releasing intrauterine system with gonadotropin-releasing hormone analog for the treatment of adenomyosis. Med Princ Pract. 2013;22:480–483.
  • Aicher B, Peil H, Peil B, et al. Pain measurement: visual analogue scale (VAS) and verbal rating scale (VRS) in clinical trials with OTC analgesics in headache. Cephalalgia. 2012;32:185–197.
  • Higham JM, O’Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol. 1990;97:734–739.
  • Cho S, Nam A, Kim H, et al. Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis. Am J Obstet Gynecol. 2008;198:373.e1–377.
  • Osada H. Uterine adenomyosis and adenomyoma: the surgical approach. Fertil Steril. 2018;109:406–417.
  • Zhou M, Chen JY, Tang LD, et al. Ultrasound-guided high-intensity focused ultrasound ablation for adenomyosis: the clinical experience of a single center. Fertil Steril. 2011;95:900–905.
  • Khan KN, Kitajima M, Hiraki K, et al. Cell proliferation effect of GnRH agonist on pathological lesions of women with endometriosis, adenomyosis and uterine myoma. Hum Reprod. 2010;25:2878–2890.
  • Rose S, Chaudhari A, Peterson CM. Mirena (Levonorgestrel intrauterine system): a successful novel drug delivery option in contraception. Adv Drug Deliv Rev. 2009;61:808–812.
  • Mu Y, Hu X, He J, et al. Serum levels of vascular endothelial growth factor and cancer antigen 125 are related to the prognosis of adenomyosis patients after interventional therapy. Int J Clin Exp Med. 2015;8:9549–9554.
  • Kil K, Chung JE, Pak HJ, et al. Usefulness of CA125 in the differential diagnosis of uterine adenomyosis and myoma. Eur J Obstet Gynecol Reprod Biol. 2015;185:131–135.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.